KN 1XX
Alternative Names: KN-1XXLatest Information Update: 01 Dec 2023
At a glance
- Originator New Cancer Cure-Bio
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer
Most Recent Events
- 06 Sep 2023 Early research in Cancer in South Korea (unspecified route) (New Cancer Cure-Bio pipeline, September 2023)